Integration of a disposable system in a traditional manufacturing process to terminal sterilization
|
|
|
- Lorena Shelton
- 10 years ago
- Views:
Transcription
1 Integration of a disposable system in a traditional manufacturing process to terminal sterilization G. Fiorentino QA Supervisor ITALFARMACO SPA Milano
2 ITALFARMACO Italy Milano plant LOCATION: Milan Italy TOTAL FACILITY AREA: m² NUMBER OF EMPLOYEES: About 160 OPERATIONS: Pharmaceutical Manufacturing
3 GROUP
4 ITALFARMACO Italy Milano plant
5 Case study description Implementation of a Single Use System in a traditional department for non cytotoxic drugs manufacturing (traditional technologies used) Reasons of the decision Project development: Choice of the system System set up System validation
6 Current traditional system 400L stainless steel preparation tank Single sterilizing filtration (terminal sterilization product): 100L stainless steel holding tank 4 vent filter 4 sterile filter (0.2 m) + 1 filter of reduction bioburden (0.45 m) Silicone Pt-cured connection tubings
7 Current traditional system Filling in Class C under LAF Class C compounding room Class A/B filtration surround C AUTOCLAVE (Sterilization of the filled ampoules) 7
8 Single Use System: Pro&Cons Advantages: Aseptic connections reduction Increase of the sterility assurance and decreased contamination risks Decrease of cleaning/cleaning validation activities Reduction of equipments costs and related activities (i.e. equipments sterilization costs) Decreased post-filling activities done by production operators
9 Single Use System: Pro&Cons Disadvantages/Risks: Possibility to introduce the Single Use System on the existing production line Single Use System costs (purchase and discharge) Increase of validation activities: Preliminary evaluation of the possibility to use the Single Use System with the defined product/s Validation related costs Regulatory risks/activities: Possible regulatory requests on Single Use System Regulatory variations necessary in case of registered products (related activities and costs) Impact on project timelines, costs and risks
10 Single Use System: conclusions Single Use System is easy introduced only in a phase/step of production process Possibility to use two alternative systems (traditional and single use) Introduction of the Single Use System easy for a product under development/new registration How to proceed with the Single Use Project??
11 Project development SUS SUS drawing SUS components: Silicone Pt-cured tubings T and Y propylene connectors Polycarbonate rapid connectors Defined system: Single Use System specific validation package
12 Validation aspects Separate validation of the filter and of the Single Use System Filter validation according to regulatory requests: Viability Challenge Extractables Integrity test values Adsorption Single Use System validation: start of combined work Italfarmaco-Supplier
13 Regulations and Guidance International Standards ICH Q1A: Stability testing of new Drug Products and Substances: Container closure system ICH Q3A, Q3B: Impurities in New Drug Substances and Products: Threshold (%) depending of the max daily dose ICH Q3C = E.P.5.4 = USP<467> (draft): Guidelines for residual solvents ICH Q7A: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients ISO part 13: Identification and quantification of degradation products from polymeric medical devices ISO (2003): Plastics containers for intravenous injection US/North America 21 CFR Part : Equipment construction Canadian Food and Drug Regulations, GMP, Part C, Division 2, Section C : Equipment FDA CDER/CBER Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics Europe EU GMP, Medicinal products for human and veterinary use, European Commission, Volume 4, chapter 3, paragraph 3.39 EMEA/205/04 Guideline on Plastic Immediate Packaging Materials Other references PDA Technical report 26: Sterilizing Filtration of Liquids (2008) PQRI publication: Safety thresholds and best practices for extractables and leachables in Orally Inhaled and Nasal Drug Products ASTM E (2006): Standard guide for determining the impact of exctractables from non-metallic materials on the safety of Biotechnology Products BPSA (Bioprocess Systems Alliance) recommendations on extractables and leachables (2008)
14 Validation aspects Supplier qualification of the single components of Single Use System: Bag: Drop test; Resistance to gamma irradiation and to Freezing test; Connection testing; Shelf life studies (leak, tensile strength; sterility; Accelerated aging; Extractables/Leachables studies; Biological Safety tests; Physicochemical tests (endotoxin, particulate) Assembling: Burst testing; Creep rupture testing; Tensile stregth testing; Functional testing (soiling test), Closure integrity testing; Water flow/pressure drop data; Extractables testing; Shelf life studies; Autoclave testing; Biological Safety testing Supplier qualification (3rd parties) of the single components of Single Use System: Tubings: Materials certificates (including manufacturing environmental classification and generic extractables in WFI) Connections and reducers: Components certificates (including manufacturing environmental classification
15 Validation Adsorption study Compatibility study Leak Test Drop Test Burst test Extractables and Leachables
16 Cost comparison Costi fissi ogni utilizzo Lavaggio WFI Energia elettrica Chemicals Manodopera (realizzazione + documentazione) Sterilizzazione Energia elettrica Altre Utilities (CS,CA, CW) Usura serbatoio / steriliz.machine Manodopera (realizzazione + documentazione) Altre utilities (IS, CA) Usura Tank / Fixed lines + Washing machine Preparazione WFI (per final rinse) Accessori per preparazione Manodopera (realizzazione + documentazione)
17 Cost comparison Costi manutenzione-validazione / Year Manutenzione preventiva tank Sostituzione membrane e O-ring Sostituzione attuatori valvole Ispezione boroscopica integrità saldature Leak test Manodopera (per tutte le voci sopra) Fermo del sistema
18 Cost comparison Manutenzione preventiva Mixing Driver Manodopera per controllo parti elettriche e meccaniche Cleaning re-validation Manodopera Materiale occorrente per campionamenti Test QC Sterilization Cycle re-validation Costi sterilizzazione Materiale occorrente per RUNs sterilizzazione (IB, ecc..) Manodopera Test QC Fermo della macchina
19 Cost comparison Costo investimento iniziale Tank Mixing driver per tank Qualifica iniziale / Validazione
20 Evaluation VALUTAZIONE BAGs Vs TANKs Costo Totale per Utilizzi / Year -40% Costo Totale Manutenzione / Year -78% Costo Totale Steriliz.Cycle re-validation / Year -100% Costo Totale Steriliz.Cycle re-validation / Year -100% % Cost Saving BAG Vs TANK 29,4% STIMA PERIODO AMMORTAMENTO < 1 YEARS
21 ITALFARMACO Italy Milano plant Main advantages of SU Technology : 1) Decrease risk of cross contamination 2) Achieve greater assurance of sterility 3) Eliminate cleaning requirements 4) Reduce maintenance requirements 5) Decrease documentation requirements 6) Reduce production cycle time 7) Reduce water requirements 8) Reduce space requirements 9) Eliminate use of hazardous cleaning fluids 10) Reduce capital investment in facility and equipment
22
23 ITALFARMACO Italy Milano plant
24 ITALFARMACO Italy Milano plant
25 Business Drivers
26 Qualification
27 Implementation
28 Validating an SUS Process validation remains the responsibility of the pharmaceutical manufacturer Leveraging supplier data requires an understanding of how it was developed Materials of construction Testing procedures (e.g. pyrogens, heavy metals, solvents, E/L) System design may require features to facilitate validation Alternate receiving vessels to accommodate testing Integrity testing Desirable, but not necessarily realistic or achievable Campaigning Surge vessels, columns
29 Validating an SUS Conclusions Suppliers are an integral part of the quality system Unprecedented levels of transparency and data sharing and management are required Those who fully embrace true partnerships will be the most successful
30 Validating an SUS Materials management - no pain, limited gain Low impact mtls are relatively easy to alternate source Decreases exposure at a single supplier Gain experience of alternative suppliers quality system Financial benefits a consideration High impact materials require more work to qualify Addresses higher risks (supply interruptions, recalls) Lower frequency of use The back-up may fail before the primary Maintain high levels of support and service from suppliers
31 G. Fiorentino QA Supervisor
How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs
WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s
FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS
FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer
Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology-
Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen -Senior Manager Biotechnology- 2005 by West Pharmaceutical Services, Inc., Lionville, PA All rights reserved.
Cleaning validation of cleanrooms and preparation equipments
Cleaning validation of cleanrooms and preparation equipments Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About Compounding" 23-25 May,
Assembly and Installation Procedures
Assembly and Installation Procedures for Pall Pharmaceutical Grade Capsule Assemblies 1. Introduction The following procedures must be followed for the installation of Pall pharmaceutical grade capsule
IMPURITIES IN NEW DRUG PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current
Regulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
Sterilization methods and equipment Lab 1-2
Sterilization methods and equipment Lab 1-2 PHT 434 Sterilization Sterilization a process that by which all viable M.O are removed or destroyed, based on a probability function. Sterilization concept Sterilization
Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE
Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle
Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.
FDA and the Compounding Pharmacy
FDA and the Compounding Pharmacy Scott Sutton, Ph.D. [email protected] 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current
Terminal Sterilization. vs. Aseptic Processing
Terminal Sterilization vs. Aseptic Processing Praphon Angtrakool Food and Drug Administration 1 Sterile Drug Products Produced by Aseptic Processing It is a well-accepted principle that sterile drugs should
Recent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
Blood, Plasma, and Cellular Blood Components INTRODUCTION
Blood, Plasma, and Cellular Blood Components INTRODUCTION This chapter of the Guideline provides recommendations to Sponsors of Requests for Revision for new monographs for blood, plasma, and cellular
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
European Medicines Agency Inspections London, 19 May 2005 CPMP/QWP/4359/03 EMEA/CVMP/205/04 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
Extemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
How To Test For Leachables
Current FDA Perspective on Leachable Impurities in Parenteral and Ophthalmic Drug products AAPS Workshop on Pharmaceutical Stability Scientific and Regulatory Considerations for Global Drug Development
Sterile Cleanroom Management
Sterile Cleanroom Management Lynn Stanard, Sr. Quality Manager, Berkshire Corporation When manufacturing in an aseptic environment, it is critical to ensure that the various cleanroom consumables, such
Lenntech [email protected] www.lenntech.com Tel. +31-15-261.09.00 Fax. +31-15-261.62.89
Lenntech Tel. +31-15-261.09.00 Fax. +31-15-261.62.89 Data Sheet Data Sheet Solvex Solvent Filtration Cartridge Filters ReliaBle api FiltRation DeSigneD to Fit your needs Optimized filtration means meeting
Guidance for Industry
Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,
VALIDATION OF ASEPTIC PROCESSES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 007-6 1 January 2011 RECOMMENDATION ON THE VALIDATION OF ASEPTIC PROCESSES PIC/S January 2011 Reproduction prohibited
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
Uncompromising Customer Service. Baumann TM Sanitary and Aseptic Process Valves
Baumann TM Sanitary and Aseptic Process Valves The Company Fisher Controls International LLC, Baumann Control Valves, is an ISO 9001 certified, PED compliant manufacturer of general utility, precision
Media fills Periodic performance qualification (Re-Validation)
Media fills Periodic performance qualification (Re-Validation) Minimum number of Simulations Number of units Contaminated Units Action a Two per Year (Retrospective & Prospective Validation) < 5000 5000
LIBRARY GUIDE. Online Courses. March 2012
LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS 5 th Edition November 2015 NHS Pharmaceutical Quality Assurance Committee 2015 British Oncology Pharmacists Association Pharmaceutical
GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.
15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2
Guidance for Industry
Guidance for Industry Class II Special Controls Guidance Document: Cord Blood Processing System and Storage Container This guidance is for immediate implementation. FDA is issuing this guidance for immediate
ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers A WHITE PAPER
A WHITE PAPER ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers By Scott Mackin A WHITE PAPER ENVIRONMENTAL TESTING & MONITORING:
LIST OF INTERNATIONAL STANDARDS FOR MEDICAL DEVICES
NO STANDARD DESCRIPTION 1. ISO 13485: 2003 Medical Devices: Quality Management System: Requirements For Regulatory Purposes 2. EN540 Clinical Investigation of Medical Devices For Human 3. EN285 Sterilization
Working with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
Annex 6. Guidance on variations to a prequalified product dossier. Preface
Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi
Water for Injection (WFI) and Pure Steam Production in a Lean Manufacturing Environment. Larry Zanko Project Manager STERIS Corporation
Water for Injection (WFI) and Pure Steam Production in a Lean Manufacturing Environment Larry Zanko Project Manager STERIS Corporation Agenda Brief overview of multiple-effect water stills (MWS) Lean advancements
Guidance for Industry
Guidance for Industry Changes to an Approved NDA or ANDA U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) April 2004 CMC Revision
Understanding USP 797
DDK Scientific, Corp. Raul Duarte June 2008 Copyright DDK Scientific, Corp. 2008, 2009 DDK Scientific, Corp. Proprietary The purpose of USP 797 is to prevent harm and fatality to patients that could result
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific
Expectations for Data to Support Clinical Trial Drugs
Expectations for Data to Support Clinical Trial Drugs Presentation to: APEC Advanced Workshop on Review of Drug Development in Clinical Trials Bangkok Thailand Feb 2-6 2009 Willem Stevens Ph.D., Chief
The BPE 2012 Edition & Project 2012 Requirements & Resources for Bioprocess Systems Design
The BPE 2012 Edition & Project 2012 Requirements & Resources for Bioprocess Systems Design Reinhard Hanselka, PhD Director of Code Compliance & Environmental Engineering, M+W Group, Alameda, CA Ray Foley
VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET P/Nno.: SDSID: 1/5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Application: For3D or metallographic replica For 3D or metallographic replica
Workflow System for Paperless Air Monitoring Powered by MODA. Presented by
Introducing Hach s MET ONE Compliance Workflow System for Paperless Air Monitoring Powered by MODA Presented by Scott Hjelmervik Bob Toal Systems Director Vice President Hach Company MODA Technology Partners
Pharmatec GmbH. Packaging Technology. Pharmatec GmbH
Packaging Technology 1 Expert s Congress 13.-14.09.2007 Pure Steam for Pharmaceutical Sterilizers Albrecht Voigt / 2 Steam for Pharmaceutical Application Content: Classification of steam Characteristic
Improving Uptime in Aseptic Processing of Pharmaceutical Liquids with Blow-Fill-Seal
Improving Uptime in Aseptic Processing of Pharmaceutical Liquids with Blow-Fill-Seal Maximized uptime, minimized changeover time and efficient OEE are key factors that have influenced the acceptance of
SERVICES FOR. Devices and Combination Products
SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,
Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA
Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels Master of Drug Regulatory Affairs
PHARMACEUTICAL AND CHEMICAL WASTE MANAGEMENT
Medicines and Medical Devices Agency of Serbia PHARMACEUTICAL AND CHEMICAL WASTE MANAGEMENT Ivana Bozic, MSc Health, Safety and Environment ISWA Beacon Conference, Novi Sad, 08 10 December 2010 458, Vojvode
GMP Regulatory Considerations
GMP Regulatory Considerations Alain Kupferman Workshop on WO prequalification requirements for reproductive health medicines, Jakarta, October 2009 REGULATORY CONSIDERATIONS CONTAINMENT PROTECTION METODS
High Potent Drugs & Containment Technology
High Potent Drugs & Containment Technology Technology Overview & Quality Risk-Based Design Selection Holger Fabritz Head of Quality & Validation Assurance Part 1 Definition High Potent Drugs, OEL & hazardous
The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?
The Management of Pharmaceuticals in the Environment (PIE) FAQ Key questions and answers Q: How do pharmaceuticals get into the environment? A: Like many foods and supplements that are consumed by humans
How To Understand Your Role In A Pharmacy
Element 1 Element 2 Assist with the maintenance of pharmaceutical Issue pharmaceutical 277 278 Element 1 Element 2 Assist with the maintenance of pharmaceutical Issue pharmaceutical Background See background
FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)
FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005) Dr.R.MANAVALAN, M.Pharm., Ph.D. Professor and Research Director, Department of Pharmaceutics,
LifeASSURE 020SP. Series Capsules & Cartridge Filters. Sterilising Grade Nylon 6,6 Membrane Filter
3M Purification Life Sciences Process Technologies Markets LifeASSURE 020SP Series Capsules & Cartridge Filters Sterilising Grade Nylon 6,6 Membrane Filter for pharmaceutical, biological & bioprocess Industries
PHARMACEUTICAL REFERENCE STANDARDS
PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,
Implementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: [email protected] Today s Agenda Handling Method Changes vs. Adjustments
REPORT FOR INTERNATIONAL COOPERATION ON COSMETIC REGULATION (ICCR)
REPORT FOR INTERNATIONAL COOPERATION ON COSMETIC REGULATION (ICCR) Principles for the handling of traces of impurities and/or contaminants in cosmetic products Report is: 1 [Choose One] Prepared For ICCR
Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing
Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Katherine L. Ulman and Dr. Patricia Rafidison Dow Corning Healthcare About the Authors
Sterile ReadyToProcess Hollow Fiber Cartridges Instructions for Use
GE Healthcare Instructions 28-9226-84 AD ReadyToProcess Sterile ReadyToProcess Hollow Fiber Cartridges Instructions for Use 1 Introduction... 1 2 Inspect the Cartridge... 1 3 General Description... 2 4
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION
1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information
Material Safety Data Sheet
Material Safety Data Sheet STAINLESS STEEL CLEANER & POLISH 1. Trade name of product Product use Code Date of issue Product and company identification Product dilution information STAINLESS STEEL CLEANER
ICH Topic Q 5 E Comparability of Biotechnological/Biological Products
European Medicines Agency June 2005 CPMP/ICH/5721/03 ICH Topic Q 5 E Comparability of Biotechnological/Biological Products Step 5 NOTE FOR GUIDANCE ON BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS SUBJECT TO CHANGES
Packaging Validation according to ISO 11607
Synergy makes sence Packaging Validation according to ISO 11607 MG-FSI72-104 Last revision: March 2011 5, Chemin du Catupolan - 69120 Vaulx en Velin - France - Tel. 33 (0)4 72 81 22 62 - Fax : 33 (0)4
Guideline on stability testing for applications for variations to a marketing authorisation
21 March 2014 EMA/CHMP/CVMP/QWP/441071/2011- Rev.2 Committee for Medicinal Products for Human Use (CHMP)/ Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on stability testing for applications
Hazard Analysis and Critical Control Points (HACCP) 1 Overview
Manufacturing Technology Committee Risk Management Working Group Risk Management Training Guides Hazard Analysis and Critical Control Points (HACCP) 1 Overview Hazard Analysis and Critical Control Point
Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle
Process Performance Qualification Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle A LIFECYCLE Approach to Process Validation? Lifecycle [ICH Q8(R2)]: All phases
Single-Use Bioreactors Meeting BioPharma Needs for Lower Operating Cost and Faster Time to Market
Single-Use Bioreactors Meeting BioPharma Needs for Lower Operating Cost and Faster Time to Market White Paper White Paper Single-use bioreactors meeting biopharma needs for lower operating cost and faster
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
Current version : 2.0.1, issued: 29.08.2012 Replaced version: 2.0.0, issued: 07.03.2012 Region: GB
SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier Trade name Easy Glide Gleitmittel 1.2 Relevant identified uses of the substance or mixture and uses
Cleanroom Packaging Protect against contamination
Cleanroom Packaging Protect against contamination Dr. Christoph Strubl STRUBL GmbH & Co. KG Kunststoffverpackungen STRUBL GmbH & Co. KG Kunststoffverpackungen, Richtweg 52, D 90530 Wendelstein Tel:+49(0)9129-9035
HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR
HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR I. INTRODUCTION A. CARAMEL COLOR 1. Caramel Color (Caramel) is defined in Title 21 of the U.S. Code of
Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI
Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the
Risk Management for Aseptic Processing
Risk Management for Aseptic Processing Ed White Welcome to The Aseptic Core. This column discusses scientific and regulatory aspects of aseptic processing, with an emphasis on aseptic formulation and filling.
www.gbo.com/bioscience Tissue Culture 1 Cell/ Microplates 2 HTS- 3 Immunology/ HLA 4 Microbiology/ Bacteriology Purpose Beakers 5 Tubes/Multi-
www.gbo.com/bioscience 11 Cryotechnics Technical Information 11 I 2 Cryo.s TM 11 I 3 Cryo.s TM 1 ml 11 I 3 Cryo.s TM 2 ml 11 I 3 Cryo.s TM 4 ml 11 I 4 Cryo.s TM 5 ml 11 I 4 Support Rack 11 I 5 Cryo Storage
Auditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
Particle Monitoring Requirements in Pharmaceutical Cleanrooms
Particle Monitoring Requirements in Pharmaceutical Cleanrooms All drugs must be manufactured in accordance with the current Good Manufacturing Practice (cgmp) regulations. Pharmaceutical manufacturers
Screw Cap Micro Tubes
Screw Cap Micro Tubes For transport, storage and sample preparation Reliable quality and versatility Sicherheit Uncompromising... quality and purity Sicherheit... Over 30 years ago, Sarstedt introduced
STABILITY TESTING: PHOTOSTABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING: PHOTOSTABILITY TESTING OF NEW
Lenntech [email protected] www.lenntech.com Tel. +31-15-261.09.00 Fax. +31-15-261.62.89
Lenntech [email protected] www.lenntech.com el. +526.9. Fax. +526.62.89 EPOR IR Filter Cartridges air / gas filters expanded PFE EPOR IR sterilization filter cartridges offer exceptional filtration performance
Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg
Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
Best Practice In A Change Management System
Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits
Durapore. High Throughput Flow Rates. Durapore 0.2 µm hydrophilic
 Durapore CBR 0.2 µm Bioburden Reduction Filters Lenntech Tel. +31-15-261.09.00 Fax. +31-15-261.62.89 DAT A SHEET For fine filtration of deionized water, in vitro diagnostics, oral suspensions, bulk pharmaceutical
Global Lab Capabilities Pharma Biotech
Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical
Product Bulletin INTEROX HYDROGEN PEROXIDE
Product Bulletin INTEROX HYDROGEN PEROXIDE UN 2014 35% - 59.5% SOLUTIONS TECHNICAL & SPECIALTY GRADES H 0 0 H Molecular weight: 34.02 FP 1.1.3 Version 03/13 Page 1 of 5 INTEROX Hydrogen Peroxide Description
Particle testing in cleanroom high-pressure gas lines to ISO 14644 made easy with the MET ONE 3400 gas calibrations
Particle testing in cleanroom high-pressure gas lines to ISO 14644 made easy with the MET ONE 3400 gas calibrations B e c k m a n C o u l t e r L i f e S c i e n c e s 2 5 0 S. K r a e m e r B o u l e
QUALITY RISK MANAGEMENT (QRM): A REVIEW
Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate
Author General Management Quality Assurance
Lab Ofichem B.V. Pag.: 1 / 14 Date: 20-01- Version: 02 Status: geldig Contents 1. General... 2 2. Shared Third Party audit program... 3 3. Reassurance absence of Conflict of Interest... 5 4. Contract structure...
4729-16-11 Hazardous Drugs Compounded by a Prescriber.
ACTION: Original DATE: 11/30/2015 8:57 AM 4729-16-11 Hazardous Drugs Compounded by a Prescriber. (A) A facility where a prescriber is compounding or handling hazardous drugs shall be licensed as a terminal
Pharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
To provide direction for the safe handling, administration and disposal of hazardous drugs.
Subsection: MEDICATION Related terms: Cytotoxic Drugs, Antineoplastic Drugs Authorized by: Clinical Directors CS-04-02-01 Page 1 of 9 Date Established: October 2006 Date For Review: September 2014 Dates
